DBR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.687970E-01
Normal-vs-Stage2
1.316840E-01
Normal-vs-Stage3
1.636130E-02
Normal-vs-Stage4
8.174400E-01
Stage1-vs-Stage2
9.595000E-01
Stage1-vs-Stage3
1.676590E-01
Stage1-vs-Stage4
2.867400E-01
Stage2-vs-Stage3
1.212150E-01
Stage2-vs-Stage4
3.855000E-01
Stage3-vs-Stage4
1.611240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.233030E-01
Normal-vs-AfricanAmerican
3.691200E-01
Normal-vs-Asian
2.921400E-01
Caucasian-vs-AfricanAmerican
5.432800E-01
Caucasian-vs-Asian
6.947200E-01
AfricanAmerican-vs-Asian
8.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.104400E-02
Normal-vs-Female
2.498600E-01
Male-vs-Female
3.891800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.998200E-02
Normal-vs-Age(41-60Yrs)
2.104600E-01
Normal-vs-Age(61-80Yrs)
1.306440E-01
Normal-vs-Age(81-100Yrs)
1.087970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.377600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.544400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.073200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.740200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.621400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.771830E-02
Normal-vs-Daily Drinker
1.938380E-02
Normal-vs-Weekly Drinker
3.555200E-01
Normal-vs-Occasional Drinker
7.082200E-01
Normal-vs-Social Drinker
1.905040E-01
Non Drinker-vs-Daily Drinker
3.402600E-01
Non Drinker-vs-Weekly Drinker
2.980800E-01
Non Drinker-vs-Occasional Drinker
3.153900E-02
Non Drinker-vs-Social Drinker
1.515780E-01
Daily Drinker-vs-Weekly Drinker
9.664300E-02
Daily Drinker-vs-Occasional Drinker
6.944300E-03
Daily Drinker-vs-Social Drinker
5.558200E-02
Weekly Drinker-vs-Occasional Drinker
3.897600E-01
Weekly Drinker-vs-Social Drinker
9.616800E-01
Occasional Drinker-vs-Social Drinker
3.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.575400E-01
Normal-vs-Grade 2
8.001600E-01
Normal-vs-Grade 3
7.865800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.925000E-03
Grade 1-vs-Grade 3
8.641800E-03
Grade 1-vs-Grade 4
9.575400E-01
Grade 2-vs-Grade 3
7.640000E-01
Grade 2-vs-Grade 4
8.001600E-01
Grade 3-vs-Grade 4
7.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.501420E-01
Normal-vs-NonDiabetic
9.221500E-02
Diabetic-vs-NonDiabetic
5.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.261510E-02
Normal-vs-NoPancreatitis
1.396420E-01
Pancreatitis-vs-NoPancreatitis
3.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.484810E-01
Normal-vs-N1
1.567840E-01
N0-vs-N1
6.038000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.500800E-01
Normal-vs-TP53-NonMutant
2.259200E-01
TP53-Mutant-vs-TP53-NonMutant
2.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
